Article Details
Retrieved on: 2021-06-04 17:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... hematological malignancies and solid tumors, today announced updated clinical data from the ZYNLONTA™ (loncastuximab tesirine-lpyl) Phase 2 ...
Article found on: www.citizentribune.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here